(Cilostazol + rosuvastatin) is under clinical development by Korea United Pharm and currently in Phase I for Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease). According to GlobalData, ...
From the Centers of Inflammation, Translational, and Clinical Lung Research (Y. Shao, Y. Sun, Y.L., F.S., C.D., C.J., K.X., X.J., X.Y.), Temple University, Lewis Katz ...
Expert Rev Clin Pharmacol. 2012;5(3):319-336. Aspirin improves clinical outcome in all cardiovascular (CV) syndromes in primary and secondary prevention, including acute events. In high-risk ...